• Login
    View Item 
    •   DSpace Home
    • SUNY Cobleskill
    • Student Publications
    • Student Research Showcase and SURC
    • SUNY Undergraduate Research Conference, Annual Conference Proceedings 2016
    • State University College at Old Westbury
    • View Item
    •   DSpace Home
    • SUNY Cobleskill
    • Student Publications
    • Student Research Showcase and SURC
    • SUNY Undergraduate Research Conference, Annual Conference Proceedings 2016
    • State University College at Old Westbury
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Metastatic Cancer: The Migration of Cancerous Cells

    Thumbnail
    View/Open
    Metastatic cancer-OldW.pdf (1.868Mb)
    Date
    2016
    Author
    Nasir, Ramish
    Metadata
    Show full item record
    Subject
    Cancer
    Cancer -- Treatment
    Carcinogens
    Abstract
    Migration is a movement from one place to another and it occurs in every aspect of life. Migration is not bound by size. In a biological sense, it can be macroscopic with the seasonal movements of an animal species, or microscopic at the cellular level of an individual organism. Most migrations that occur at the cellular level of an organism are required for health and survival. However, some rare migrations can have adverse and even deadly effects. One example of this type of migration is in cancer. When these migrations occur, the cancer becomes metastatic; the malignant cell migrates from its origin to another location in the body. This occurs due to a process called EMT, or Epithelial Mesenchymal Transition. At the point EMT occurs the immune system process have to come to the Escape stage of immunoediting, where instead of fighting the malignant cells, the immune system supports their growth and transition. If an individual's cancer has reached a metastatic level, it is very hard to fight the cancer. Cancer is the second leading cause of deaths after heart disease. Fortunately, a lot of research has been going into curing cancer with some promising results. Since every cancer is unique and complicated, most treatments are unique to each patient. If a patient has metastatic cancer the theoretical course of treatment would be to use chemo and radiotherapy to kill metastatic cells and reduce the size of the parent tumor. The poster presentation will look into new studies that focus on gene therapy such as down regulating certain oncogenes and upregulating others, as well as therapies that stop the migration of the malignant cells. Such therapies would look at ways to reverse EMT to MET (mesenchymal to epithelial transition). Would targeting CHD5 and/or its family of proteins such as SUV39H1 or SIRT halt the metastatic process?
    URI
    http://hdl.handle.net/1951/67536
    Collections
    • State University College at Old Westbury [2]

    SUNY Digital Repository Support
    DSpace software copyright © 2002-2022  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV
     

     


    SUNY Digital Repository Support
    DSpace software copyright © 2002-2022  DuraSpace
    Contact Us | Send Feedback
    DSpace Express is a service operated by 
    Atmire NV